A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

NCT01712906 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Mumps

Interventions

BIOLOGICAL: 3.50±0.25logCCID50/ml
BIOLOGICAL: 4.25±0.25 logCCID50/ml
BIOLOGICAL: 5.00±0.25 logCCID50/ml
BIOLOGICAL: 0 logCCID50/ml
BIOLOGICAL: Attenuated Mumps vaccine (Zhe Jiang Vacn Bio-pharmaceutical Co., LTD.; NO.20110528-1)

Sponsor

Institute of Medical Biology, Chinese Academy of Medical Sciences

Collaborators

[object Object]